Up Close with Elranatamab
Last Updated: May 13, 2026
Discover more about elranatamab-bcmm (ELREXFIO™).
Related Resources:
Treatment Support Kit
Treatment Support Kit: Elranatamab
PQI
PQI: Elranatamab (Elrexfio) for the Management of Relapsed/Refractory Multiple Myeloma
Last Updated: 08/03/2025
Perspectives
OncolyticsToday: The Bispecific Antibody Revolution
Author: KELLY BRUNK
Last Updated: 04/01/2024
Find Similar Resources:
Immunotherapy
Immunotherapy
Immunotherapy
Immunotherapy
Overview of BTCEs: Comparison of Bispecific T-Cell Engagers (BTCEs)
Last Updated: 04/23/2026
Example SOPs and Documents: Transitioning Patients on Bispecific T-Cell Engagers Between Care Settings
Last Updated: 07/01/2025
Example SOPs and Documents: Bispecific T-cell Engager Billing Procedure
Last Updated: 07/01/2025
Up Close with Linvoseltamab
Last Updated: 05/16/2025
PQI
Patient Education Sheet
Patient Education Sheet
Patient Education Sheet
PQI: Encorafenib (Braftovi) + Cetuximab (Erbitux) + FOLFIRI for BRAF V600E-Positive Metastatic Colorectal Cancer
Last Updated: 05/15/2026
Cyclophosphamide, Bortezomib, and Dexamethasone
Last Updated: 05/12/2026
Sirolimus
Last Updated: 05/11/2026
Tacrolimus
Last Updated: 05/11/2026